Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization

J Am Coll Cardiol. 2011 Jun 14;57(24):2444-52. doi: 10.1016/j.jacc.2010.11.069.

Abstract

Objectives: This study was designed to compare the effectiveness of Sonic hedgehog (Shh) gene transfer, AMD3100-induced progenitor-cell mobilization, and Shh-AMD3100 combination therapy for treatment of surgically induced myocardial infarction (MI) in mice.

Background: Shh gene transfer improves myocardial recovery by up-regulating angiogenic genes and enhancing the incorporation of bone marrow-derived progenitor cells (BMPCs) in infarcted myocardium. Here, we investigated whether the effectiveness of Shh gene therapy could be improved with AMD3100-induced progenitor-cell mobilization.

Methods: Gene expression and cell function were evaluated in cells cultured with medium collected from fibroblasts transfected with plasmids encoding human Shh (phShh). MI was induced in wild-type mice, in matrix metalloproteinase (MMP)-9 knockout mice, and in mice transplanted with bone marrow that expressed green-fluorescent protein. Mice were treated with 100 μg of phShh (administered intramyocardially), 5 mg/kg of AMD3100 (administered subcutaneously), or both; cardiac function was evaluated echocardiographically, and fibrosis, capillary density, and BMPC incorporation were evaluated immunohistochemically.

Results: phShh increased vascular endothelial growth factor and stromal cell-derived factor 1 expression in fibroblasts; the medium from phShh-transfected fibroblasts increased endothelial-cell migration and the migration, proliferation, and tube formation of BMPCs. Combination therapy enhanced cardiac functional recovery (i.e., left ventricular ejection fraction) in wild-type mice, but not in MMP-9 knockout mice, and was associated with less fibrosis, greater capillary density and smooth muscle-containing vessel density, and enhanced BMPC incorporation.

Conclusions: Combination therapy consisting of intramyocardial Shh gene transfer and AMD3100-induced progenitor-cell mobilization improves cardiac functional recovery after MI and is superior to either individual treatment for promoting therapeutic neovascularization.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzylamines
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Cyclams
  • Disease Models, Animal
  • Gene Transfer Techniques
  • Genetic Therapy / methods*
  • Hedgehog Proteins / administration & dosage*
  • Heterocyclic Compounds / pharmacology*
  • Humans
  • Injections, Intralesional
  • Injections, Subcutaneous
  • Mice
  • Mice, Knockout
  • Myocardial Infarction / pathology
  • Myocardial Infarction / therapy*
  • Neovascularization, Physiologic / physiology*
  • Random Allocation
  • Sensitivity and Specificity
  • Stem Cells / metabolism*
  • Survival Rate
  • Treatment Outcome
  • Ventricular Remodeling / physiology*

Substances

  • Benzylamines
  • Cyclams
  • Hedgehog Proteins
  • Heterocyclic Compounds
  • Shh protein, mouse
  • plerixafor